BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 25878104)

  • 1. Antibody escape kinetics of equine infectious anemia virus infection of horses.
    Schwartz EJ; Nanda S; Mealey RH
    J Virol; 2015 Jul; 89(13):6945-51. PubMed ID: 25878104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of equine infectious anemia virus escape from neutralizing antibody responses define epitope specificity.
    Sponseller BA; Clark SK; Friedrich RA
    Viral Immunol; 2012 Aug; 25(4):324-8. PubMed ID: 22746986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling Mutation in Equine Infectious Anemia Virus Infection Suggests a Path to Viral Clearance with Repeated Vaccination.
    Schwartz EJ; Costris-Vas C; Smith SR
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of a rare neutralization-resistant variant following passive transfer of convalescent immune plasma in equine infectious anemia virus-challenged SCID horses.
    Taylor SD; Leib SR; Carpenter S; Mealey RH
    J Virol; 2010 Jul; 84(13):6536-48. PubMed ID: 20392850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics of lentiviral infection in vivo in the absence of adaptive immune responses.
    Schwartz EJ; Vaidya NK; Dorman KS; Carpenter S; Mealey RH
    Virology; 2018 Jan; 513():108-113. PubMed ID: 29055819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of antibody parameters as potential correlates of protection or enhancement by experimental vaccines to equine infectious anemia virus.
    Hammond SA; Raabe ML; Issel CJ; Montelaro RC
    Virology; 1999 Sep; 262(2):416-30. PubMed ID: 10502520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discerning an effective balance between equine infectious anemia virus attenuation and vaccine efficacy.
    Craigo JK; Li F; Steckbeck JD; Durkin S; Howe L; Cook SJ; Issel C; Montelaro RC
    J Virol; 2005 Mar; 79(5):2666-77. PubMed ID: 15708986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responses in horses infected with equine infectious anemia virus adapted to tissue culture.
    Gutekunst DE; Becvar CS
    Am J Vet Res; 1979 Jul; 40(7):974-7. PubMed ID: 228570
    [No Abstract]   [Full Text] [Related]  

  • 9. An attenuated EIAV vaccine strain induces significantly different immune responses from its pathogenic parental strain although with similar in vivo replication pattern.
    Lin YZ; Shen RX; Zhu ZY; Deng XL; Cao XZ; Wang XF; Ma J; Jiang CG; Zhao LP; Lv XL; Shao YM; Zhou JH
    Antiviral Res; 2011 Nov; 92(2):292-304. PubMed ID: 21893100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-neutralizing and subclass characteristics of antibody from horses with equine infectious anemia virus.
    O'Rourke KI; Perryman LE; McGuire TC
    Vet Immunol Immunopathol; 1989 Nov; 23(1-2):41-9. PubMed ID: 2559537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic T lymphocytes and neutralizing antibody in the control of equine infectious anemia virus.
    McGuire TC; Fraser DG; Mealey RH
    Viral Immunol; 2002; 15(4):521-31. PubMed ID: 12513924
    [No Abstract]   [Full Text] [Related]  

  • 12. Protective effects of broadly neutralizing immunoglobulin against homologous and heterologous equine infectious anemia virus infection in horses with severe combined immunodeficiency.
    Taylor SD; Leib SR; Wu W; Nelson R; Carpenter S; Mealey RH
    J Virol; 2011 Jul; 85(13):6814-8. PubMed ID: 21543497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune selection of equine infectious anemia virus env variants during the long-term inapparent stage of disease.
    Sponseller BA; Sparks WO; Wannemuehler Y; Li Y; Antons AK; Oaks JL; Carpenter S
    Virology; 2007 Jun; 363(1):156-65. PubMed ID: 17328936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus.
    Hammond SA; Li F; McKeon BM; Cook SJ; Issel CJ; Montelaro RC
    J Virol; 2000 Jul; 74(13):5968-81. PubMed ID: 10846078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equine infectious anemia and equine infectious anemia virus in 2013: a review.
    Cook RF; Leroux C; Issel CJ
    Vet Microbiol; 2013 Nov; 167(1-2):181-204. PubMed ID: 24183747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and characterization of an equine infectious anemia virus Env-pseudotyped reporter virus.
    Tallmadge RL; Brindley MA; Salmans J; Mealey RH; Maury W; Carpenter S
    Clin Vaccine Immunol; 2008 Jul; 15(7):1138-40. PubMed ID: 18448619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity of serum neutralizing antibodies induced by transient immune suppression of inapparent carrier ponies infected with a neutralization-resistant equine infectious anemia virus envelope strain.
    Howe L; Craigo JK; Issel CJ; Montelaro RC
    J Gen Virol; 2005 Jan; 86(Pt 1):139-149. PubMed ID: 15604441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemagglutination-inhibition tests with different strains of equine infectious anemia virus.
    Sentsui H; Kono Y
    Am J Vet Res; 1981 Nov; 42(11):1949-52. PubMed ID: 6175255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine specificity of equine infectious anaemia virus gp90-specific antibodies associated with protective and enhancing immune responses in experimentally infected and immunized ponies.
    Grund CH; Lechman ER; Pezzuolo NA; Issel CJ; Montelaro RC
    J Gen Virol; 1996 Mar; 77 ( Pt 3)():435-42. PubMed ID: 8601778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of serum antibodies to equine infectious anemia virus reverse transcriptase.
    DeVico AL; Issel CJ; Le Grice SF; Payne SL; Montelaro RC; Sarngadharan MG
    AIDS Res Hum Retroviruses; 1993 Jan; 9(1):7-11. PubMed ID: 7678974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.